Eris Lifesciences Q2 Profit Rises 39% to ₹187 Crore
Eris Lifesciences reported consolidated net profit of ₹187.14 crore for the September quarter, up 39% from ₹134.47 crore a year earlier. The company cited growth in its domestic branded formulations business.